Target intelligence / Profile preview

Enterotoxigenic Escherichia coli heat-labile toxin (LT)

Target
LT
Molecular classification
AB5-type toxin, Enzyme, ADP-ribosyltransferase, Bacterial toxin
01

Overview

Enterotoxigenic Escherichia coli heat-labile toxin (LT) is a potent AB5-type protein exotoxin produced by ETEC, a leading cause of secretory diarrhea in children in developing countries and traveler's diarrhea worldwide. Structurally and functionally similar to cholera toxin (CT), LT consists of a catalytic A-subunit and a pentameric B-subunit that mediates binding to GM1 gangliosides on the surface of intestinal epithelial cells. Once internalized, the A-subunit ADP-ribosylates the Gs-alpha subunit of G proteins, causing persistent activation of adenylate cyclase and an overproduction of cyclic AMP. This signaling cascade leads to the efflux of chloride ions and water into the intestinal lumen, resulting in profuse watery diarrhea. Due to its potent immunomodulatory properties, LT and its non-toxic derivatives are extensively studied as mucosal adjuvants and are primary targets for vaccine development, including oral formulations that provide cross-protection against cholera.

Other names
Heat-labile enterotoxinE. coli heat-labile toxinLT-ILT-IILT enterotoxinLTB (B-subunit)LTA (A-subunit)
02

Mechanism of action

The toxin's B-subunit pentamer binds to GM1 ganglioside receptors on intestinal epithelial cells, facilitating the entry of the A-subunit. Inside the cell, the A-subunit acts as an ADP-ribosyltransferase, covalently modifying the Gs-alpha subunit of the heterotrimeric G protein. This results in the constitutive activation of adenylate cyclase, leading to a massive increase in intracellular cyclic AMP (cAMP) levels, which triggers the opening of chloride channels (CFTR) and inhibits sodium absorption, causing watery diarrhea.

03

Biological functions

ADP-ribosylation of Gs-alpha proteinActivation of adenylate cyclaseStimulation of cAMP productionInduction of electrolyte and water secretionMucosal adjuvanticityBinding to GM1 ganglioside
04

Disease associations

InfectionTraveler's diarrheaChildhood diarrhea
05

Safety considerations

Severe dehydration and electrolyte imbalanceHigh reactogenicity of the wild-type toxin in vaccinesPotential for Bell's palsy when administered intranasally as an adjuvantNeed for detoxification (e.g., dLT or LTB) for safe therapeutic/preventative use
06

Interacting drugs

Oral cholera vaccine (Dukoral)

3 more in the full profile.

07

Biomarkers

LT-specific IgA in stoolLT-specific IgG/IgA in serumFecal LT protein detection (ELISA)ETEC DNA/RNA in stool (PCR)

Beyond the preview

Go deeper on Enterotoxigenic Escherichia coli heat-labile toxin (LT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterotoxigenic Escherichia coli heat-labile toxin (LT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call